Adagio offers first peek at Covid-19 antibody data, with preventative numbers that may rival mRNA vaccines

Tillman Gerngross certainly wasn’t the first to tackle Covid-19 antibodies, but he has reason to believe he and his team at Adagio could be the …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ada­gio of­fers first peek at Covid-19 an­ti­body da­ta, with pre­ven­ta­tive num­bers that may ri­val mR­NA vac­cines